- Home
- KXIN vs CLDI Comparison
KXIN vs CLDI Comparison
Compare KXIN & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- CLDI
- Stock Information
- Founded
- KXIN 2015
- CLDI 2014
- Country
- KXIN China
- CLDI United States
- Employees
- KXIN N/A
- CLDI N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KXIN Consumer Discretionary
- CLDI Health Care
- Exchange
- KXIN Nasdaq
- CLDI Nasdaq
- Market Cap
- KXIN 13.0M
- CLDI 14.0M
- IPO Year
- KXIN N/A
- CLDI N/A
- Fundamental
- Price
- KXIN $0.92
- CLDI $0.50
- Analyst Decision
- KXIN
- CLDI Strong Buy
- Analyst Count
- KXIN 0
- CLDI 2
- Target Price
- KXIN N/A
- CLDI $15.00
- AVG Volume (30 Days)
- KXIN 88.8K
- CLDI 301.3K
- Earning Date
- KXIN 01-01-0001
- CLDI 05-13-2025
- Dividend Yield
- KXIN N/A
- CLDI N/A
- EPS Growth
- KXIN N/A
- CLDI N/A
- EPS
- KXIN N/A
- CLDI N/A
- Revenue
- KXIN N/A
- CLDI N/A
- Revenue This Year
- KXIN N/A
- CLDI N/A
- Revenue Next Year
- KXIN N/A
- CLDI N/A
- P/E Ratio
- KXIN N/A
- CLDI N/A
- Revenue Growth
- KXIN N/A
- CLDI N/A
- 52 Week Low
- KXIN $0.64
- CLDI $0.35
- 52 Week High
- KXIN $29.52
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- KXIN 44.49
- CLDI 42.97
- Support Level
- KXIN $0.86
- CLDI $0.46
- Resistance Level
- KXIN $0.94
- CLDI $0.51
- Average True Range (ATR)
- KXIN 0.09
- CLDI 0.05
- MACD
- KXIN -0.00
- CLDI 0.02
- Stochastic Oscillator
- KXIN 16.21
- CLDI 83.01
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.